A prominent Wall Street equity index firm says it's trying to help investors profit from environmentally conscious holdings.» Read More
But for its renewables commitment BP really deserves due credit, as does its earnest engagement in shaping what they acknowledge is a ‘carbon-constrained world.’ That's a phrase this reporter first heard more than three years ago from Jim Rogers...
Petrobras, the Brazilian oil producer that’s rapidly emerging as one of the world’s top companies, is “finding very good results” at its newly discovered off-shore deposits, Chief Executive Jose Sergio Gabrielli de Azevedo told CNBC in an exclusive interview.
There is a notable omission, one that exposes a fundamental contradiction, not just in this well-meaning company, but in across the energy sector, struggling to adjust to a carbon-constrained world.
Syngenta, Monsanto and Bunge should be bought on any discount, Cramer says.
The world's biggest oil companies depend on Nordic American to lug their product across the globe. With the price per barrel at all-time highs, it's a good business to be in.
Muscular retail sales figures encouraged traders -- as the dollar slips again and crude oil continues to soar. How should investors read these ostensibly contradictory signs? Erik Ristuben of Russell Investment Group and Holly Isdale of Lehman Brothers offered their sector insights to CNBC.
Chevron, the second-largest U.S. oil company, said Friday its first-quarter earnings rose 10 percent as record oil prices outweighed weak profits from gasoline production.
Exxon Mobil posted disappointing first-quarter earnings, as record crude oil prices did not help the company as much as investors hoped.
What's wrong with this picture? Crude oil is on a tear, but ExxonMobil shares have barely budged in NINE months. Can tomorrow's earnings knock the oil giant out of its trading range?
Stocks closed mixed in thin trading Tuesday as the tide turned in technology's favor. Airline stocks rose as oil prices receded. Merck skidded after an FDA rejection.
Stocks pushed higher Tuesday despite concerns about interest rates ahead of the Federal Reserve's decision. Merck skidded after an FDA rejection. Airline stocks rose as oil prices receded.
Stocks declined Tuesday amid concerns about interest rates and a slide in consumer confidence. Merck dragged on the Dow industrials after the FDA rejected a key cholesterol drug.
Tuesday could be another wait-and-see day in the markets as investors count down to the Fed's Wednesday afternoon interest rate announcement. But it may be earnings news that has the biggest sway over stocks.
Stocks finished flat Monday as concerns about the Federal Reserve's rate decision in a couple of days kept a lid on activity generated by merger buzz.
Stocks ticked higher Monday amid merger buzz but index gains were modest as the market awaits the Federal Reserve's rate decision later this week.
Stocks retreated after an early pop Monday as the early market buzz was all about deals and deal makers.
Exxon Mobil, Royal Dutch Shell and BP are expected to report bumper first-quarter profits next week, thanks to record crude prices, but $110 per barrel oil will also squeeze refining profits and delay a return to oil production growth.
Oil settled up over $118 -- down from its intra-day high above $119 -- aafter a workers strike cut production in Nigeria and tensions rose between the United States and Iran
China has accumulated a stake of just under 1 percent in BP, raising fresh questions about Beijing's strategy for investing its huge foreign currency reserves.
Two of the world’s biggest oil companies, BP and ConocoPhillips, will spend billions to build a pipeline from the North Slope to feed energy-hungry markets in the United States and Canada, the New York Times reports.